KK
Kristen Kluska Cantor Fitzgerald Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
40
Avg Return
Past Year
Past Year
12%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
71.4%
Neutral
28.6%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Upgraded
| $9 |
27%
downside
| 1 | -67% |
0
%
| 2 Mar ‘26 4 days ago |
|
|
|
Overweight
Maintained
| $125 |
110%
upside
| 1 | +9.2% |
0
%
| 17 Feb ‘26 17 days ago |
|
|
|
Overweight
Maintained
| $19 |
139%
upside
| 1 | +30% |
0
%
| 15 Jan ‘26 1 month ago |
|
|
|
Neutral
Downgraded
| $14.50 |
1%
upside
| 1 | +18% |
–
| 19 Dec ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $48 |
115%
upside
| 2 | +11% |
0
%
| 17 Dec ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $24 |
194%
upside
| 1 | +25% |
0
%
| 8 Dec ‘25 2 months ago |
|